Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-18-001444
Filing Date
2018-07-10
Accepted
2018-07-10 09:27:34
Documents
4
Period of Report
2018-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv498235_6k.htm 6-K 12299
2 EXHIBIT 99.1 tv498235_ex99-1.htm EX-99.1 13637
3 EXHIBIT 99.2 tv498235_ex99-2.htm EX-99.2 226217
4 GRAPHIC tv498235_ex99-1img01.jpg GRAPHIC 16647
  Complete submission text file 0001279569-18-001444.txt   276440
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 18946116
SIC: 2834 Pharmaceutical Preparations